Screener
McKesson MCK Restructuring Reserve
Restructuring Reserve at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by McKesson in its filing.
Tagged under the XBRL concept us-gaap:RestructuringReserve.
The source filing: McKesson’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:29 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000927653-26-000234
| (In millions) | North American Pharmaceutical | Prescription Technology Solutions | Medical-Surgical Solutions | Corporate | Total |
|---|---|---|---|---|---|
| Balance, March 31, 2026 (1) | $18 | $3 | $10 | $13 | $44 |
| Restructuring, impairment, and related charges, net | 2 | 61 | 23 | 50 | 136 |
| Non-cash charges | (1) | (40) | — | (6) | (47) |
| Cash payments | (3) | — | (16) | (40) | (59) |
| Balance, June 30, 2026 (2) | $16 | $24 | $17 | $17 | $74 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is McKesson's restructuring reserve?
- McKesson (MCK) reported restructuring reserve of $74M in Q2 2026.
- How has McKesson's restructuring reserve changed year-over-year?
- McKesson's restructuring reserve decreased by 15.9% year-over-year, from $88M to $74M.
- What is the long-term trend for McKesson's restructuring reserve?
- Over 5 years (2021 to 2026), McKesson's restructuring reserve has grown at a -21.9% compound annual growth rate (CAGR), from $151M to $44M.
- What does restructuring reserve mean?
- This represents the estimated liability for costs associated with formal restructuring plans, such as severance, facility closures, or asset impairments. It reflects management's commitment to operational efficiency and strategic realignment. These reserves are drawn down as the restructuring activities are executed.
Ask your AI about McKesson's restructuring reserve.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude